One molecule. Every way it is sold.
NAD Picks is an independent review desk covering NAD⁺ — the injections, IV drips, nasal sprays, patches and oral precursors people are sold, and the companies selling them. We exist because the gap between what the trials show and what NAD⁺ is marketed as is enormous, and because in this category the cheapest option happens to have the best evidence behind it — which is not what most of the internet will tell you.
No parent company, no outside owner, no entity behind the name — just the site. We are paid by affiliate commissions from some of the providers here, we disclose it on every page it applies to, and the products we rate best on evidence are ones we earn nothing from.
We attach no degrees or affiliations to our writers, and there is no licensed clinician on staff as a medical reviewer — we say so rather than implying otherwise, and that is why a medical disclaimer sits on our health pages. What we do instead is check everything against the primary source before it publishes, and date every price to the month we read it off the seller’s own page.
Who writes NAD⁺ Picks
Laura Bennett
Evidence & trialsWhat the NAD⁺ trials actually measured, and what they did not.
View profile →Michael Reyes
Cost & accessWhat NAD⁺ therapy costs per milligram, and what the headline price hides.
View profile →Rachel Kim
Biochemistry & mechanismThe salvage pathway, the precursors, and where mechanism outruns evidence.
View profile →James Harper
Formats & deliveryInjection, IV, intranasal, transdermal, oral — and what reaches the bloodstream.
View profile →Read more about how we work in our methodology and disclosures.